The thiazide-sensitive NaCl cotransporter (NCC) mediates salt reabsorption in the distal nephron (DN) of the kidney and is a key determinant of the blood pressure set point. With-No-Lysine (WNK) kinases regulate NCC membrane trafficking, phosphorylation status, and activity. One member of this family, WNK1, is expressed in the distal nephron as two major classes of isoforms with opposing functions. Long isoforms of WNK1 that possess intact serine-threonine kinase activity (L-WNK1) stimulate NCC. In contrast, short kidney-specific WNK1 isoforms that lack a kinase domain (KS-WNK1) inhibit NCC by antagonizing L-WNK1. Prior work indicates that the balance of these kinase-active and -defective products controls NCC activity, effectively functioning as an isoform switch. The upstream mechanisms regulating WNK1 isoform balance, however, remain obscure. Our preliminary data suggest that aldosterone is a physiologically relevant stimulus that signals through the WNK1 switch to activate NCC-mediated salt reabsorption in the kidney. This proposal is driven by three novel observations: (1) First, in DN cell lines, aldosterone increases total WNK1 protein expression, but has a stronger effect on kinase active L-WNK1 than kinase defective KS-WNK1; this triggers downstream signaling events that increase NCC plasma membrane abundance and phosphorylation. (2) Second, WNK1 isoforms enriched at the protein level in the DN contain PY motifs- sequences which bind to Nedd4-2, an E3 ubiquitin ligase whose activity is suppressed by aldosterone. (3) Third, although KS-WNK1 transcript levels are high in the DN, it is an inherently unstable protein, and comparative studies with L-WNK1 indicate striking differences in steady state expression and protein turnover. Based on these findings, we hypothesize that aldosterone increases the total protein abundance of WNK1 isoforms in the distal nephron via Nedd4-2 inhibition, adjusting their ratio to favor increased L-WNK1 activity and NCC activation. To critically test this model, we propose to answer three questions about the regulation of WNK1 isoforms that remain incompletely addressed. First, how does the inhibition of Nedd4-2 by aldosterone regulate WNK1 protein expression and NCC activation? Second, why do L-WNK1 and KS-WNK1 exhibit different protein turnover rates? Third, how does aldosterone affect the WNK1 isoform switch in vivo? Answering these questions should provide novel insights into the molecular basis of aldosterone action, NCC regulation, and blood pressure homeostasis. Completion of the proposed aims will therefore improve our understanding of the pathogenesis of essential hypertension and highlight new strategies for its treatment.
High blood pressure places one third of the U.S. population at risk for end stage kidney disease, stroke, and death from heart disease. The kidney regulates blood pressure by controlling the rate of urinary salt excretion. This proposal seeks to understand how a blood pressure regulatory hormone, aldosterone, fine-tunes salt handling in the kidney by adjusting the balance of two molecules, L-WNK1 and KS-WNK1. By understanding how this balance is achieved, the studies will provide insights into the regulation of blood pressure in health and disease while identifying new strategies for treatment.
|Mackie, Timothy D; Kim, Bo-Young; Subramanya, Arohan R et al. (2018) The endosomal trafficking factors CORVET and ESCRT suppress plasma membrane residence of the renal outer medullary potassium channel (ROMK). J Biol Chem 293:3201-3217|
|Tomilin, Viktor N; Zaika, Oleg; Subramanya, Arohan R et al. (2018) Dietary K+ and Cl- independently regulate basolateral conductance in principal and intercalated cells of the collecting duct. Pflugers Arch 470:339-353|
|Boyd-Shiwarski, Cary R; Shiwarski, Daniel J; Roy, Ankita et al. (2018) Potassium-regulated distal tubule WNK bodies are kidney-specific WNK1 dependent. Mol Biol Cell 29:499-509|
|O'Donnell, Brighid M; Mackie, Timothy D; Subramanya, Arohan R et al. (2017) Endoplasmic reticulum-associated degradation of the renal potassium channel, ROMK, leads to type II Bartter syndrome. J Biol Chem 292:12813-12827|
|Boyd-Shiwarski, Cary R; Subramanya, Arohan R (2017) The renal response to potassium stress: integrating past with present. Curr Opin Nephrol Hypertens 26:411-418|
|Al-Qusairi, Lama; Basquin, Denis; Roy, Ankita et al. (2017) Renal Tubular Ubiquitin-Protein Ligase NEDD4-2 Is Required for Renal Adaptation during Long-Term Potassium Depletion. J Am Soc Nephrol 28:2431-2442|
|Bhuiyan, Mohammad Iqbal H; Song, Shanshan; Yuan, Hui et al. (2017) WNK-Cab39-NKCC1 signaling increases the susceptibility to ischemic brain damage in hypertensive rats. J Cereb Blood Flow Metab 37:2780-2794|
|Webb, Tennille N; Carrisoza-Gaytan, Rolando; Montalbetti, Nicolas et al. (2016) Cell-specific regulation of L-WNK1 by dietary K. Am J Physiol Renal Physiol 310:F15-26|
|Pereira, Ester M; Labilloy, Anatália; Eshbach, Megan L et al. (2016) Characterization and phosphoproteomic analysis of a human immortalized podocyte model of Fabry disease generated using CRISPR/Cas9 technology. Am J Physiol Renal Physiol 311:F1015-F1024|
|Al-Qusairi, Lama; Basquin, Denis; Roy, Ankita et al. (2016) Renal tubular SGK1 deficiency causes impaired K+ excretion via loss of regulation of NEDD4-2/WNK1 and ENaC. Am J Physiol Renal Physiol 311:F330-42|
Showing the most recent 10 out of 13 publications